Skip to main content
Year archive

IMUGENE LIMITED — 2020 filings

All 90 regulatory filings released by IMUGENE LIMITED (IMU) in 2020, sourced directly from the official regulator.

90 Filings
2020 Period
2020 filings (90)
Filing Released Lang
Change of Director's Interest Notice - PH 5 pages 324.3KB
Director's Dealing
2020-12-22 English
Change of Director's Interest Notice - LC 3 pages 199.6KB
Director's Dealing
2020-12-22 English
Proposed issue of Securities - IMU 5 pages 27.1KB
Capital/Financing Update
2020-12-21 English
Appendix 2A 15 pages 394.8KB
Regulatory Filings
2020-12-21 English
Imugene Enrols First Cohort of PD1-Vaxx Clinical Trial 2 pages 130.2KB
Regulatory Filings
2020-12-16 English
Change of Director's Interest Notice - AH 3 pages 199.0KB
Director's Dealing
2020-12-16 English
Changes to Executive Chairman Remuneration 2 pages 106.2KB
Remuneration Information
2020-12-15 English
Proposed issue of Securities - IMU 5 pages 28.1KB
Capital/Financing Update
2020-12-15 English
Appendix 2A 15 pages 388.6KB
Capital/Financing Update
2020-12-15 English
Appendix 3G 12 pages 349.5KB
Share Issue/Capital Change
2020-12-15 English
Imugene Receives $4.82 million R&D Tax Incentive 2 pages 134.2KB
Capital/Financing Update
2020-12-09 English
Proposed issue of Securities - IMU 6 pages 30.1KB
Capital/Financing Update
2020-12-08 English
Appendix 2A and 708A Notice 17 pages 5.0MB
Capital/Financing Update
2020-12-08 English
Change of Director's Interest Notice - CW 3 pages 182.8KB
Director's Dealing
2020-12-07 English
Appendix 3G 12 pages 452.3KB
Share Issue/Capital Change
2020-12-02 English
Imugene First Patient Dosed in PD1-VAXX Clinical Trial 2 pages 126.4KB
Regulatory Filings
2020-11-30 English
Proposed issue of Securities - IMU 6 pages 31.1KB
Capital/Financing Update
2020-11-30 English
Appendix 2A 16 pages 483.5KB
Capital/Financing Update
2020-11-30 English
Appendix 2A 15 pages 395.6KB
Regulatory Filings
2020-11-26 English
AGM Presentation 14 pages 1.2MB
AGM Information
2020-11-23 English
Investor Presentation 31 pages 1.6MB
Investor Presentation
2020-11-23 English
Results of Meeting 2 pages 108.8KB
Declaration of Voting Results & Voting Rights Announcements
2020-11-23 English
Proposed issue of Securities - IMU 6 pages 30.2KB
Capital/Financing Update
2020-11-23 English
Appendix 2A 15 pages 387.7KB
Regulatory Filings
2020-11-23 English
Imugene HER Vaxx shows positive Overall Survival in trial 3 pages 132.0KB
Regulatory Filings
2020-11-22 English
Release of Securities from Escrow 1 page 99.6KB
Share Issue/Capital Change
2020-11-17 English
Proposed issue of Securities - IMU 6 pages 30.3KB
Capital/Financing Update
2020-11-16 English
Appendix 2A 15 pages 387.8KB
Capital/Financing Update
2020-11-16 English
Appendix 2A 15 pages 388.1KB
Capital/Financing Update
2020-11-09 English
Proposed issue of Securities - IMU 6 pages 30.3KB
Capital/Financing Update
2020-11-09 English
Becoming a substantial holder 2 pages 6.0MB
Regulatory Filings
2020-11-03 English
Proposed issue of Securities - IMU 6 pages 30.3KB
Capital/Financing Update
2020-11-03 English
Appendix 2A 15 pages 473.3KB
Capital/Financing Update
2020-11-03 English
Imugene Receives FDA IND Approval for PD1-VAXX Trial in USA 2 pages 111.3KB
Regulatory Filings
2020-11-01 English
Letter to IMUOA Optionholders 3 pages 934.5KB
Share Issue/Capital Change
2020-11-01 English
Appendix 4C - quarterly 8 pages 376.2KB
Interim / Quarterly Report
2020-10-26 English
Proposed issue of Securities - IMU 6 pages 30.3KB
Capital/Financing Update
2020-10-21 English
Appendix 2A 15 pages 388.8KB
Regulatory Filings
2020-10-21 English
Notice of Annual General Meeting/Proxy Form 94 pages 2.5MB
AGM Information
2020-10-20 English
Proposed issue of Securities - IMU 6 pages 30.3KB
Capital/Financing Update
2020-10-14 English
Appendix 2A 15 pages 388.0KB
Capital/Financing Update
2020-10-14 English
Proposed issue of Securities - IMU 6 pages 30.3KB
Capital/Financing Update
2020-10-06 English
Appendix 2A 15 pages 388.2KB
Capital/Financing Update
2020-10-06 English
Imugene Immunotherapy Combination Patent Granted in US 2 pages 131.9KB
Regulatory Filings
2020-10-01 English
Imugene appoints Dr Rita Laeufle as Chief Medical Officer 2 pages 141.3KB
Board/Management Information
2020-09-29 English
Letter to IMUOA & IMUOB Option Share Holders 3 pages 939.3KB
Capital/Financing Update
2020-09-29 English
Proposed issue of Securities - IMU 6 pages 30.3KB
Capital/Financing Update
2020-09-22 English
Appendix 2A 15 pages 387.8KB
Capital/Financing Update
2020-09-22 English
Imugene Secures $5.7 million Option Underwriting Agreement 2 pages 150.1KB
Capital/Financing Update
2020-09-08 English
Proposed issue of Securities - IMU 5 pages 27.1KB
Capital/Financing Update
2020-09-08 English
Appendix 2A 15 pages 404.5KB
Regulatory Filings
2020-09-08 English
Imugene Receives PD1-VAXX Ethics Trial Approval in USA 2 pages 130.4KB
Regulatory Filings
2020-09-02 English
Proposed issue of Securities - IMU 5 pages 28.1KB
Capital/Financing Update
2020-08-31 English
Appendix 2A 15 pages 381.0KB
Capital/Financing Update
2020-08-31 English
Appendix 4E & Annual Report to shareholders 96 pages 5.1MB
Regulatory Filings
2020-08-30 English
Corporate Governance Statement 6 pages 200.5KB
Governance Information
2020-08-30 English
Appendix 4G 11 pages 229.9KB
Governance Information
2020-08-30 English
Proposed issue of Securities - IMU 5 pages 28.0KB
Capital/Financing Update
2020-08-24 English
Appendix 2A 15 pages 795.4KB
Regulatory Filings
2020-08-24 English
Imugene Receives Third PD1-VAXX Ethics Trial Approval 2 pages 124.7KB
Regulatory Filings
2020-08-20 English
Proposed issue of Securities - IMU 5 pages 28.1KB
Capital/Financing Update
2020-08-17 English
Appendix 2A 15 pages 796.8KB
Regulatory Filings
2020-08-17 English
Change of Director's Interest Notice - CW 2 pages 183.5KB
Director's Dealing
2020-08-11 English
Letter to IMUOA Option Share Holders 1 page 281.5KB
Capital/Financing Update
2020-08-06 English
Change of Director's Interest Notice - CW & AH 5 pages 205.9KB
Director's Dealing
2020-08-06 English
Imugene Receives Clinical Guidance from US FDA for Vaxinia 3 pages 147.9KB
Regulatory Filings
2020-08-05 English
Appendix 2A and 708A Notice 16 pages 1.0MB
Capital/Financing Update
2020-08-04 English
CEO and Managing Director increases shareholding in Imugene 1
Director's Dealing
2020-08-04 English
Change of Director's Interest Notice - LC 3 pages 323.8KB
Director's Dealing
2020-08-04 English
Proposed issue of Securities - IMU 8 pages 34.4KB
Capital/Financing Update
2020-08-03 English
Appendix 4C - quarterly 8 pages 420.0KB
Interim / Quarterly Report
2020-07-26 English
Imugene Receives Second PD1-VAXX Ethics Trial Approval 3 pages 153.0KB
Regulatory Filings
2020-07-16 English
Imugene Receives Ethics Approval to Start PD1-VAXX Trial 3 pages 153.3KB
Regulatory Filings
2020-07-13 English
New mimotope cancer vaccine results published 2 pages 146.9KB
Regulatory Filings
2020-05-27 English
Release of Securities from Escrow 1 page 265.8KB
Share Issue/Capital Change
2020-05-14 English
Imugene HER-Vaxx Phase 2 Clinical Update 3 pages 112.4KB
Regulatory Filings
2020-05-03 English
IMU Presents PD1-Vaxx Clinical Plan at AACR Annual Meeting 2 pages 137.0KB
Investor Presentation
2020-04-26 English
IMU Presents Vaxinia Clinical Plan at AACR Annual Meeting 2 pages 135.3KB
Regulatory Filings
2020-04-26 English
Appendix 4C - quarterly 7 pages 480.9KB
Interim / Quarterly Report
2020-04-23 English
Change of Director's Interest Notice - LR 2 pages 180.6KB
Director's Dealing
2020-03-29 English
Change of Director's Interest Notice - CW 2 pages 182.5KB
Director's Dealing
2020-03-24 English
Change of Director's Interest Notice - CW 2 pages 176.7KB
Director's Dealing
2020-03-17 English
Change of Director's Interest Notice - LC 2 pages 182.8KB
Director's Dealing
2020-03-16 English
Change of Director's Interest Notice - LC 2 pages 181.6KB
Director's Dealing
2020-03-12 English
Change of Director's Interest Notice - CW 2 pages 184.3KB
Director's Dealing
2020-03-10 English
Half Yearly Report and Accounts 34 pages 6.1MB
Interim / Quarterly Report
2020-02-25 English
Ceasing to be a substantial holder 2 pages 89.9KB
Regulatory Filings
2020-02-12 English
Appendix 4C - quarterly 7 pages 354.8KB
Interim / Quarterly Report
2020-01-30 English
Imugene PD1-Vaxx Immunotherapy Update 2 pages 136.4KB
Regulatory Filings
2020-01-27 English
Imugene HER-Vaxx Immunotherapy Patent Granted in US 2 pages 122.1KB
Regulatory Filings
2020-01-13 English